Prenatal morphine exposure alters ovarian steroid hormonal regulation of seizure susceptibility

Brain Research

Volumn 796, Issue 1-2, 1998, Pages 247-256

  Velíšek, Libor ^a,b   Velíšková, Jana ^a   Moshé, Solomon L ^a   Vathy, Ilona ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Brainstem; Convulsion; Entorhinal cortex; Estrogen; Flurothyl; Forebrain; Low magnesium; Progesterone

Indexed keywords

ESTROGEN; FLUROTHYL; MAGNESIUM; MORPHINE; PROGESTERONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN SLICE; BRAIN STEM; CLONIC SEIZURE; CONTROLLED STUDY; ENTORHINAL CORTEX; EPILEPTIC DISCHARGE; FEMALE; FOREBRAIN; HORMONAL REGULATION; NONHUMAN; OVARIECTOMY; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; RAT; SEIZURE SUSCEPTIBILITY; SEIZURE THRESHOLD;

ANIMALS; CONVULSANTS; DISEASE SUSCEPTIBILITY; ENTORHINAL CORTEX; EPILEPSY; ESTROGENS; FEMALE; FLUROTHYL; MAGNESIUM; MORPHINE; NARCOTICS; OVARIECTOMY; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; PROGESTERONE; RATS; SEIZURES;

EID: 0032526845     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)00367-9     Document Type: Article

References (70)

1. Adler M.W., Lin C.-H., Keinath S.H., Braverman S., Geller E.B. Anticonvulsant action of acute morphine administration in the rat. J. Pharm. Exp. Ther. 198:1976;655-660.
2. Albertson T.E., Joy R.M., Stark L.G. Modification of kindled amygdaloid seizures by opiate agonists and antagonists. J. Pharm. Exp. Ther. 228:1984;620-627.
3. Backstrom T. Epileptic seizures in women related to plasma estrogen and progesterone during the menstrual cycle. Acta Neurol. Scand. 54:1976;321-347.
4. Bardo M.T., Bhatnagar R.K., Gebhart G.F. Differential effects of chronic morphine and naloxone on opiate receptors, monoamines and morphine-induced behaviours in pre-weaning rats. Dev. Brain Res. 4:1982;139-147.
5. Behnke M., Eyler F.D. The consequences of prenatal substance use for the developing fetus, newborn and young child. Int. J. Addict. 28:1993;1341-1391.
6. Bohme G.A., Stutzmann J.M., Roques B.P., Blanchart J.C. Effects of selective μ- and δ-opioid peptides on kindled amygdaloid seizures in the rats. Neurosci. Lett. 74:1987;227-231.
7. Bowdler J.M., Green A.R. Regional rat brain benzodiazepine receptor number and γ-aminobutyric acid concentration following a convulsion. Br. J. Pharmacol. 76:1982;291-298.
8. Browning R.A. Role of the brainstem reticular formation in tonic-clonic seizures: lesion and pharmacological studies. Fed. Proc. 44:1985;2425-2431.
9. Browning R.A., Nelson D.K. Modification of electroshock and pentylenetetrazol seizure patterns in rats after precollicular transections. Exp. Neurol. 93:1986;546-556.
10. Cain D.P., Corcoran M.E. Intracerebral β-endorphin, met-enkephalin and morphine: kindling of seizures and handling-induced potentiation of epileptiform effects. Life Sci. 34:1984;2535-2542.
11. Castellano C., Ammassari-Teule M. Prenatal exposure to morphine in mice: enhanced responsiveness to morphine and stress. Pharmacol. Biochem. Behav. 21:1984;103-108.
12. Cowan A., Geller E.B., Adler M.W. Classification of opioids on the basis of change in seizure threshold in rats. Science. 206:1979;465-467.
13. Cowan A., Tortella F.C., Adler M.W. A comparison of the anticonvulsant effects of two systemically active enkephalin analogues in rats. Eur. J. Pharmacol. 1971:1981;117-121.
14. Davis W.M., Lin C.H. Prenatal morphine effects on survival and behavior of rat offspring. Res. Commun. Chem. Pathol. Pharmacol. 3:1972;205-214.
15. Di Giulio A.M., Tenconi B., Malosio M.L., Vergani L., Bertelli A., Gorio A. Perinatal morphine: I. Effects on synapsin and neurotransmitter systems in the brain. J. Neurochem. Res. 42:1995;479-485.
16. Dreier J.P., Heinemann U. Late low magnesium-induced epileptiform activity in rat entorhinal cortex slices becomes insensitive to the anticonvulsant valproic acid. Neurosci. Lett. 119:1990;68-70.
17. 2+ induced epileptiform activity in rat temporal cortex slices. Exp. Brain Res. 87:1991;581-596.
18. H.H. Feder, Estrous cyclicity in mammals, in: N.T. Adler (Ed.), Neuroendocr. Reprod., Plenum, New York, London, 1981.
19. Fisher W., Bodewei R., Von Voigtlander P.F., Muller M. Anticonvulsant and related effects of U-54494A in various seizure tests. J. Pharmacol. Exp. Ther. 267:1993;163-170.
20. Frenk H., Engel J.J., Ackermann R.F. Endogenous opioids may mediate postictal behavioral depression in amygdaloid-kindled rats. Brain Res. 167:1979;435-440.
21. Green A.R., Metz A., Minchin M.C., Vincent N.D. Inhibition of the rate of GABA synthesis in regions of rat brain following a convulsion. Br. J. Pharmacol. 92:1987;5-11.
22. Green A.R., Minchin M.C., Vincent N.D. Inhibition of GABA release from slices prepared from several brain regions of rats at various times following a convulsion. Br. J. Pharmacol. 92:1987;13-18.
23. Helmchen H., Kunkel H., Selbach H. Periodic influences on the individual frequency of epileptic seizures. Arch. Psychiatr. Nervenkr. 206:1964;293-308.
24. Hom A.C., Buterbaugh G.G. Estrogen alters the acquisition of seizures kindled by repeated amygdala stimulations or pentylenetetrazol administration in ovariectomized female rats. Epilepsia. 27:1986;103-108.
25. Jackson H.C., Nutt D.J. Investigation of the different types of opioid receptor involved in electroconvulsive shock-induced antinociception and catalepsy in the rat. J. Pharm. Pharmacol. 43:1991;640-643.
26. Jones L.S. Naloxone blocks antiepileptogenic properties of an in vitro electroconvulsive shock model. Brain Res. 564:1991;336-340.
27. C.K. Kellogg, Benzodiazepines and the developing nervous system: laboratory findings and clinical implications, in: I.S. Zagon, T.A. Slotkin (Eds.), Maternal substance abuse and the developing nervous system, Academic Press, San Diego, 1992, pp. 283-321.
28. Kirby M., Holtzman S.G. Effects of chronic opiate administration on spontaneous activity of fetal rats. Pharmacol. Biochem. Behav. 16:1981;263-269.
29. Koyuncuoglu H., Aricioglu F. Prenatal exposure to morphine or naloxone intensifies morphine dependence at maturity. Pharmacol. Biochem. Behav. 44:1993;939-941.
30. Laidlaw J. Catamenial epilepsy. Lancet. 2:1956;1235-1237.
31. J.M. Lauder, Ontogeny of the serotonergic system in the rat: serotonin as a developmental signal, in: P.M. Whitaker-Azmitia, S.J. Perutka (Eds.), The Neuropharmacology of Serotonin, Vol. 600, Ann. New York Acad. Sci., New York, 1990, pp. 297-314.
32. Lauretti G.R., Ahmad I., Pleuvry B.J. The activity of opioid analgesics in seizures models utilizing N-methyl-DL-aspartate, kainic acid, bicuculline and pentylenetetrazole. Neuropharmacology. 33:1994;155-160.
33. Mattson R., Cramer J.A. Epilepsy, sex hormones and antiepileptic drugs. Epilepsia. 26(Suppl. 1):1985;S40-S51.
34. 2+ of NMDA responses in spinal cord neurons. Nature. 309:1984;261-263.
35. McEwen B.S. Gonadal and adrenal steroids regulate neurochemical and structural plasticity of the hippocampus via cellular mechanisms involving NMDA receptors. Cell. Mol. Neurobiol. 16:1996;103-116.
36. Nicoletti F., Speciale C., Sortino M.A., Summa G., Caruso G., Patti F., Canonico P.L. Comparative effects of estradiol benzoate, the antiestrogen clomiphene citrate, and the progestin medroxyprogesterone acetate on kainic acid-induced seizures in male and female rats. Epilepsia. 26:1985;252-257.
37. Pfaff D., Keiner M. Atlas of estradiol-concentrating cells in the central nervous system of the female rat. J. Comp. Neurol. 151:1973;121-158.
38. Pinsky C., Dua A.K., LaBella F.S. Peptidase inhibitors reduce opiate narcotic withdrawal signs, including seizure activity, in the rat. Brain Res. 243:1982;301-307.
39. Prichard J.W., Gallagher B.B., Glaser G.H. Experimental seizure threshold testing with flurothyl. J. Pharmacol. Exp. Ther. 166:1969;170-178.
40. Przewlocka B., Lason W., Machelska H., van Luijtelaar G., Coenen A., Przewlocki R. κ opioid receptor agonists suppress absence seizures in WAG/Rij rats. Neurosci. Lett. 186:1995;131-134.
41. Ricalde A.A., Hammer R.P.J. Perinatal opiate treatment delays growth of cortical dendrites. Neurosci. Lett. 115:1990;137-143.
42. Rimanóczy A., Vathy I. Prenatal exposure to morphine alters brain μ opioid receptor characteristics in rats. Brain Res. 690:1995;245-248.
43. Rocha L., Engel J.J., Ackermann R.F. Effects of chronic naloxone pretreatment on amygdaloid kindling in rats. Epilepsy Res. 10:1991;103-110.
44. Schwartz-Giblin S., Korotzer A., Pfaff D.W. Steroid hormone effects on picrotoxin-induced seizures in female and male rats. Brain Res. 476:1989;240-247.
45. Simerly R.B., Chang C., Muramatsu M., Swanson L.W. Distribution of androgen and estrogen receptor mRNA-containing cells in the rat brain: an in situ hybridization study. J. Comp. Neurol. 294:1990;76-95.
46. R.B. Simerly, C. Chang, M. Muramatsu, L.W. Swanson, Distribution of androgen and estrogen receptor mRNA-containing cells in the rat brain: an in situ hybridization study, in: F.J. Seil (Ed.), Advances in Neurology, Vol. 59, Raven Press, New York, 1990, pp. 207-226.
47. Sobrian S.K. Prenatal morphine administration alters behavioral development in the rat. Pharmacol. Biochem. Behav. 7:1977;285-288.
48. Spiegel E., Wycis H. Anticonvulsant effects of steroids. J. Lab. Clin. Med. 30:1945;947-953.
49. Stitt S.L., Kinnard R.J. The effect of certain progestins and estrogen on the threshold of electrically-induced seizure patterns. Neurology. 18:1968;213-216.
50. F.C. Tortella, E. Echevarria, L. Robles, H.I. Mosberg, J.W. Holaday, Anticonvulsant effects of μ (DAGO) and δ (DPDPE) enkephalins in rats, Peptides (1988) 1177-1181.
51. Tsang D., Ng S.C. Effects of antenatal exposure to opiates on the development of opiate receptors in rat brain. Brain Res. 188:1980;199-206.
52. van Baar A.L. Development after prenatal exposure to cocaine, heroin and methadone. Acta Paediatr. Suppl. 404:1994;40-46.
53. van Baar A.L., de Graff B.M.T. Cognitive development at preschool-age of infants of drug-dependent mothers. Dev. Med. Child Neurol. 36:1994;1063-1075.
54. Vathy I., Kátay L. Effects of prenatal morphine on adult sexual behavior and brain catecholamines in rats. Dev. Brain Res. 73:1992;115-122.
55. I. Vathy, A. Rimanóczy, Gestational morphine exposure alters ovarian hormone regulation of δ and κ opioid receptors in female rats, Neuroscience, in press.
56. Vathy I., Etgen A.M., Barfield R.J. Effects of prenatal exposure to morphine on the development of sexual behavior in rats. Pharmacol. Biochem. Behav. 22:1985;227-232.
57. Vathy I., Rimanóczy A., Eaton R.C., Kátay L. Modulation of catecholamine turnover rate in brain regions of rats exposed prenatally to morphine. Brain Res. 662:1994;209-215.
58. I. Vathy, J. Velíšková, S.L. Moshé, Prenatal morphine exposure induces age-related changes in seizure susceptibility in male rats, Pharmacol. Biochem. Behav., in press.
59. Velíšek L., Mareš P. Differential effects of naloxone on postictal depression. Epilepsy Res. 12:1992;37-43.
60. 2+-induced seizures in combined entorhinal cortex-hippocampal slices. Exp. Brain Res. 101:1994;44-52.
61. Velíšek L., Kusá R., Kulovaná M., Mareš P. Excitatory amino acid antagonists and pentylenetetrazol-induced seizures during ontogenesis: I. The effects of 2-amino-7-phosphonoheptanoate. Life Sci. 46:1990;1349-1357.
62. Velíšek L., Velíšková J., Ptachewich Y., Ortíz J., Shinnar S., Moshé S.L. Age-dependent effects of GABA agents on flurothyl seizures. Epilepsia. 36:1995;636-643.
63. Walther H., Lambert J.D.C., Jones R.S.G., Heinemann U., Hamon B. Epileptiform activity in combined slices of the hippocampus, subiculum and entorhinal cortex during perfusion with low magnesium. Neurosci. Lett. 69:1986;156-161.
64. Wilson M.A. Influence of gender, gonadectomy and estrous cycle on GABA/BZ receptors and benzodiazepine responses in rats. Brain Res. Bull. 29:1992;165-172.
65. Wilson M.A., Biscardi R. Effects of gender and gonadectomy on responses to chronic benzodiazepine receptor agonist exposure in rats. Eur. J. Pharmacol. 215:1992;99-107.
66. Woolley D.E., Timiras P.S. The gonad-brain relationship: effects of female sex hormones on electroshock convulsions in the rat. Endocrinology. 70:1962;196-209.
67. Zagon I.S., McLaughlin P.J. Morphine and brain growth retardation in the rat. Pharmacology. 15:1977;276-282.
68. Zagon I.S., McLaughlin P.J. Identification of opioid peptides regulating proliferation of neurons and glia in the developing nervous system. Brain Res. 542:1991;318-323.
69. I.S. Zagon, P.J. McLaughlin, Maternal exposure to opioids and the developing nervous system; laboratory findings, in: I.S. Zagon, T.A. Slotkin (Eds.), Maternal substance abuse and the developing nervous system, Academic Press, San Diego, 1992, pp. 241-282.
70. Zagon I.S., McLaughlin P.J., Thompson C.I. Learning ability in adult female rats perinatally exposed to methadone. Pharmacol. Biochem. Behav. 10:1979;889-894.